Recent studies in leukaemia (Martin et al, 2010) and CRC (Ying et al, 2008; Ahn et al, 2011) have shown that a major mechanism for Wnt5a downregulation is promoter hypermethylation. This evidence concerns the gene WNT5A and colorectal carcinoma.